Breast and prostate cancer cell line oncogenic characteristics are reduced when Cbl is knocked down, and, in breast cancer cells, independent of its ligase activity, Cbl mediates suppression of transcriptional activity induced by the tumour suppressor transforming growth factor-β1 [15, 16]. The gene discussed is CBL; the disease is prostate cancer.